I personally believe that ANP is at a pivotal moment. The progression from early-stage trials many years back to P3 now brings us so much closer to potential commercialization, which could significantly elevate the company's market cap, hopefully mirroring Sarepta's $7.5 billion valuation. That'll be about $5 that itsagas has been talking about.
This progress is not just a milestone for ANP but a huge success for the Australian biotech sector. It will certainly instill vibrancy to the Australian biotech sector, make every Australian proud and energize the ASX to attract more foreign money here. Shouldn't we come together to support ANP's journey, strengthen its market cap and accelerate its progress towards P3 success? How about itsagas forms and leads an interest group to support ANP instead of wasting time here to wrangle with the unbelievers or shortists??
I personally believe that ANP is at a pivotal moment. The...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.9¢ | 7.6¢ | $148.9K | 1.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48919 | 7.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 70000 | 1 |
View Market Depth
| Last trade - 15.59pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
0.000 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.9¢ | 7.7¢ | 43057 | ||
| Last updated 13.04pm 03/05/2024 ? | |||||
| PER (ASX) Chart |